# DCP - Clinical Trials Regulatory & Monitoring Support for US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network

> **NIH NIH N01** · LEIDOS BIOMEDICAL RESEARCH, INC. · 2024 · $28,537

## Abstract

The Contractor shall conduct program analysis activities upon request and provide on-site staff to assist in creation of product development plans for vaccines and therapeutics. The Contractor shall provide information and knowledge in areas including but not limited to: product (vaccine or therapeutic) development analysis; creation of target product profiles; preclinical strategy; manufacturing capacity analysis; regulatory strategy; clinical development strategy with transition plan to advanced phase clinical testing; candidate down-selection strategy; and market analysis of public-private partnerships. The Contractor shall identify deficiencies in these areas, and independently close those deficiencies using their skills and abilities and those of subcontractors.

## Key facts

- **NIH application ID:** 11053301
- **Project number:** 75N91019D00024-P00035-759102000003-48
- **Recipient organization:** LEIDOS BIOMEDICAL RESEARCH, INC.
- **Principal Investigator:** LEONARD FREEDMAN
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $28,537
- **Award type:** —
- **Project period:** 2020-08-31 → 2024-08-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11053301

## Citation

> US National Institutes of Health, RePORTER application 11053301, DCP - Clinical Trials Regulatory & Monitoring Support for US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (75N91019D00024-P00035-759102000003-48). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/11053301. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*